Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2026-02-20 @ 1:32 PM
Study NCT ID:
NCT06390267
Status:
COMPLETED
Last Update Posted:
2025-08-01
First Post:
2024-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction
Sponsor:
Spark Biomedical, Inc.
Organization:
Study Overview
Official Title:
Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction
Status:
COMPLETED
Status Verified Date:
2025-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ASR
Brief Summary:
The objective of this study is to test the effects of transcutaneous auricular neurostimulation (tAN) in treating or preventing performance degradation after an acute stressor.
Detailed Description:
This study is designed as a randomized, double-blind, sham-controlled trial. Sixty healthy, able-bodied participants will be randomized 1:1:2:2 into one of four experimental groups:
Group 1: Active tAN for prophylactic treatment prior to acute stress exposure (N=10)
Group 2: Sham stimulation for prophylactic treatment prior to acute stress exposure (N=10)
Group 3: Active tAN for acute treatment during acute stress exposure (N=20)
Group 4: Sham stimulation for acute treatment during acute stress exposure (N=20)
Participants will complete a baseline performance of three tasks. tAN treatment will then be administered prior to or during an acute stress test. Participants will complete the same three tasks preformed at baseline. In addition to the tAN therapy earpiece, subjects will have biosensors attached to them to collect biomarker information.
Group 1: Active tAN for prophylactic treatment prior to acute stress exposure (N=10)
Group 2: Sham stimulation for prophylactic treatment prior to acute stress exposure (N=10)
Group 3: Active tAN for acute treatment during acute stress exposure (N=20)
Group 4: Sham stimulation for acute treatment during acute stress exposure (N=20)
Participants will complete a baseline performance of three tasks. tAN treatment will then be administered prior to or during an acute stress test. Participants will complete the same three tasks preformed at baseline. In addition to the tAN therapy earpiece, subjects will have biosensors attached to them to collect biomarker information.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
True
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: